The new disclosure concerns the company’s response and its proposed trading arrangements. The trading suspension itself did not happen on Friday: NYSE American announced it on November 10, alongside delisting proceedings prompted by the stock’s low selling price. Keeping those dates separate makes clear what the latest announcement adds.
The Review Deadline Passed Without a Request
According to Tessera, it could have submitted a written request for review of the regulatory staff’s determination by November 17. The company said it did not do so. Its announcement did not explain why, leaving no basis to assign a particular motive.
The exchange cited Section 1003(f)(v) of its Company Guide concerning a low stock selling price. Its November 10 announcement said an application to the U.S. Securities and Exchange Commission to delist the shares would follow completion of the applicable procedures, including any company appeal.
The SEC database also contains a NYSE American Form 25-NSE removal notification concerning Tessera’s common stock, signed November 20. That is a separate procedural step from the trading suspension. The signature date alone should not be treated as the date when every legal consequence took effect.
Pink Limited Now, OTCQB as a Goal
Tessera said its common stock was quoted on OTC Markets’ Pink Limited Market under HLSQ. Its intention to apply for the OTCQB Venture Market is not an announcement of approval. The company also cautioned that an active trading market might not develop or be maintained.
Separately, Tessera said it was consulting outside counsel about a possible future national securities exchange listing, conditional on meeting initial listing standards. It said it did not currently meet the minimum share price requirements. Neither a future application nor its approval is guaranteed.
Reporting Obligations Continue
The company, formerly BiomX, now describes its business as physical security technology integrating cameras, sensors and information analysis. That description does not change the exchange’s stated reason for the delisting process: the stock price.
Tessera stressed that suspension and delisting do not end its obligation to submit periodic and current SEC reports, and said it intended to keep filing them. For those following the company, subsequent disclosures about quotation status and any new applications will matter. An intention to apply is not permission to trade on a different venue, nor does it establish the price or liquidity available when a transaction is attempted.